MedPath

VItamin C in Thermal injuRY: The VICToRY Trial

Phase 3
Recruiting
Conditions
Thermal Burn
Shock
Interventions
Drug: placebo
Registration Number
NCT04138394
Lead Sponsor
Clinical Evaluation Research Unit at Kingston General Hospital
Brief Summary

This study aims to show that giving high dose, intravenous vitamin C in addition to standard care to burned critically ill patients will be associated with less organ dysfunction, improved survival and a quicker rate of recovery. In this study, all patients will receive standard care and of the patients will also receive high dose intravenous vitamin C, while the other half of patients will receive placebo.

Detailed Description

In certain disease states, such as those associated with severe burns and other critical illnesses, the relationship between nutrient deficiencies, altered immune status, and acquired infection has been recognized for many years. More than in any other injury, the inflammation and catabolism associated with severe burns can exacerbate nutrient deficiencies, thereby predisposing patients to impaired immune function and increased risk of developing infectious complications, organ dysfunction, and death.

We aim to conduct a large-scale, multi-center randomized trial to evaluate the effect of high-dose (50mg/kg every 6 hours for 96 hours) intravenous vitamin C in addition to standard of care (SOC) on 28-days composite outcome of Persistent Organ Dysfunction (POD) and all-cause mortality compared to add-on placebo and SOC.

Patients will be allocated to 2 groups, active or control: patients in the active group will receive intravenous vitamin C at 50mg/kg every 6 hrs for 96 hrs. Patients in the control group will receive a similar amount of placebo (either D5W or saline) delivered in the same manner as the vitamin C. This study will be the first large international multi-centre trial examining the effects of high dose intravenous vitamin C in burn patients. It represents a unique collaboration of burn units worldwide that is coordinated by the Clinical Evaluation Research Unit, based in Kingston Ontario Canada, a coordinating center that has demonstrated the ability to run multi-center trials and translate findings into practice.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
666
Inclusion Criteria
  • 18 years of age or older
  • Deep 2nd and/or 3rd degree burns requiring skin grafting
  • Minimum burn size of β‰₯ 20% Total Body Surface Area (TBSA)
Exclusion Criteria
  • >24 hours from admission to participating hospital to consent.
  • Patients admitted to burn unit >24 from injury or accident.
  • Patients who are moribund (not expected to survive the next 72 hours).
  • Pregnancy (pregnancy will be ruled out as part of standard of care) or lactating.
  • Enrollment in another industry sponsored ICU intervention study.
  • Receiving high-dose IV vitamin C already (enteral or oral vitamin C is allowed).
  • Known glucose-6-phosphate dehydrogenase (G6PD) deficiency.
  • Recent history of kidney stones (within the last year).
  • Concomitant use of hydroxycobalamin (vitamin B12) for suspected cyanide poisoning.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Control groupplaceboPatients will receive a similar amount of placebo (either D5W or saline) delivered in the same manner as the vitamin C.
Vitamin CAscorbic AcidPatients will receive intravenous vitamin C at 50mg/kg every 6 hours for 96 hours
Primary Outcome Measures
NameTimeMethod
Persistent Organ Dysfunction + Deathat 28 days

Persistent organ dysfunction (PODS)+death, a novel composite endpoint that combines being alive and being free of organ support (inotropes or vasopressors, renal replacement therapy and mechanical ventilation)

Time to discharge alive from hospital90 days

Time to discharge alive from hospital, a composite of mortality and length of stay is similar to "ventilator- free days", which is a widely accepted and commonly used outcome in intensive care research.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (34)

Ascension Columbia St. Mary's

πŸ‡ΊπŸ‡Έ

Milwaukee, Wisconsin, United States

Grand Hopital de Charleroi

πŸ‡§πŸ‡ͺ

Charleroi, Hainaut, Belgium

Ghent University Hospital

πŸ‡§πŸ‡ͺ

Ghent, Oost Vlaanderen, Belgium

Belgium Military Hospital, Military Hospital

πŸ‡§πŸ‡ͺ

Brussels, Belgium

Centre Hospitalier Universitaire de Liege

πŸ‡§πŸ‡ͺ

Liège, Belgium

QEII Health Sciences Centre

πŸ‡¨πŸ‡¦

Halifax, Nova Scotia, Canada

The University of Chicago Medical Center

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

University of Texas Health Science Center - Houston

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

Harborview Medical Center - Seattle

πŸ‡ΊπŸ‡Έ

Seattle, Washington, United States

Arizona Burn Center Valleywise Health

πŸ‡ΊπŸ‡Έ

Phoenix, Arizona, United States

Bridgeport Hospital

πŸ‡ΊπŸ‡Έ

Bridgeport, Connecticut, United States

MedStar Washington Hospital Center

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

University of Iowa Hospitals & Clinics

πŸ‡ΊπŸ‡Έ

Iowa City, Iowa, United States

Mercy Hospital St. Louis

πŸ‡ΊπŸ‡Έ

Saint Louis, Missouri, United States

The Ohio State University Medical Center

πŸ‡ΊπŸ‡Έ

Ohio City, Ohio, United States

UT Southwestern Medical Center

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

Hamilton General Hospital, Hamilton Health Sciences Corporation

πŸ‡¨πŸ‡¦

Hamilton, Ontario, Canada

Sunnybrook Health Sciences Centre, Ross Tilley Burn Centre

πŸ‡¨πŸ‡¦

Toronto, Ontario, Canada

Centre de recherche du CHUM

πŸ‡¨πŸ‡¦

MontrΓ©al, Quebec, Canada

CHU de QuΓ©bec-UniversitΓ© Laval, HΓ΄pital de l'Enfant-JΓ©sus

πŸ‡¨πŸ‡¦

QuΓ©bec, Canada

Hospital San Juan de Dios

πŸ‡¨πŸ‡·

San JosΓ©, Costa Rica

BG Klinik TΓΌbingen

πŸ‡©πŸ‡ͺ

TΓΌbingen, Baden-WΓΌrttemberg, Germany

Klinikum St. George

πŸ‡©πŸ‡ͺ

Leipzig, Saxonia, Germany

RWTH Aachen University, Aachen

πŸ‡©πŸ‡ͺ

Aachen, Germany

Merheim Medical Center, Hospitals of Cologne

πŸ‡©πŸ‡ͺ

Cologne, Germany

Berufsgenossenschaftliche Unfallklinik Ludwigshafen

πŸ‡©πŸ‡ͺ

Ludwigshafen, Germany

University Hospital WΓΌrzburg

πŸ‡©πŸ‡ͺ

WΓΌrzburg, Germany

Hospital Central Dr. Ignacio Morones Prieto

πŸ‡²πŸ‡½

San Luis PotosΓ­, Mexico

Centro Nacional del Quemado y CirugΓ­as Reconstructivas

πŸ‡΅πŸ‡Ύ

AsunciΓ³n, Paraguay

Siriraj Hospital, Mahidol University

πŸ‡ΉπŸ‡­

Bangkok, Thailand

Chelsea and Westminster Hospital

πŸ‡¬πŸ‡§

Chelsea, London, United Kingdom

Queen Elizabeth Hospital Birmingham

πŸ‡¬πŸ‡§

Birmingham, Mindelsohn Way, United Kingdom

St Helens and Knowsley Hospitals NHS Trust

πŸ‡¬πŸ‡§

Prescot, United Kingdom

The Mid Yorkshire Hospitals NHS Trust

πŸ‡¬πŸ‡§

Wakefield, United Kingdom

Β© Copyright 2025. All Rights Reserved by MedPath